EMEsteban Javier Pérez Moreno

Esteban Javier Pérez Moreno

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Esteban Javier Pérez Moreno has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prevalence of intestinal parasitism in preschool and school children in Colombia: Systematic review and meta‐analysis

    by Fredy A. Pazmiño, Andrés Felipe Mora‐Salamanca, Brenda Stefania Pérez Mahecha, Esteban Javier Pérez Moreno, Mario J. Olivera, Angelica Knudson Ospina, Myriam Consuelo López

    Objective: Intestinal parasitic infections (IPIs) are a public health challenge in developing countries such as Colombia, causing anaemia and delayed growth and development in children. We aimed to estimate the geographical and prevalence trend of IPIs in the last 30 years in school and preschool children in Colombia.Methods: We conducted a systematic review and meta‐analysis. We identified potential manuscripts through PubMed, EMBASE, Web of Science, LILACS, Scielo and Google Scholar on the IPIs prevalence in school and preschool children in Colombia. Articles included in the qualitative analysis were published between 1990 and 2020 in English or Spanish and met the inclusion criteria. Subsequently, a random‐effects meta‐analysis, a meta‐regression and a trend analysis were performed.Results: We identified 2292 articles; 109 were included in the qualitative review, and 79 articles were included in the meta‐analysis. The estimated IPI prevalence was 55% (95% CI: 48–63). By age group, the prevalence in preschool children was 37% (95% CI: 26–49) and 66% (95% CI: 52–78) in schoolchildren. The prevalence by region was heterogeneous, with the Amazon being the highest (69%) and the Santanderes the lowest (28%). In the last 20 years, the prevalence of helminthiasis has decreased (from 64.66% in 1990–1995 to 22.09% in 2016–2020).Conclusion: The prevalence of IPIs is high (>30%) in three of the seven regions in Colombia. Biannual administration of mass deworming in schoolchildren is recommended in the Amazon region. Public policies aiming to control IPIs should be reinforced. Further prevalence studies should include Cesar, Guaviare, Vichada and Vaupés, where the epidemiology of IPIs is unknown.Sustainable Development Goals: Good health and wellbeing, clean water and sanitation, sustainable cities and communities.


  • Open Access

    Uso de metformina y un inhibidor de SGLT2 en el manejo de lipodistrofia congénita generalizada. Reporte de caso

    by Angélica María González-Clavijo, Luis Felipe Fierro-Maya, Juan David Muñoz-Loaiza, Daniel Perilla-Roa, Esteban Javier Pérez-Moreno, Jennifer Daniela Guzmán-Rojas, Juan Esteban Herrera-Cardona

    Introducción. La lipodistrofia congénita generalizada (LCG) es un síndrome genético autosómico recesivo extremadamente raro que se caracteriza por ausencia generalizada de tejido adiposo, deficiencia en la producción de hormonas como la leptina y complicaciones metabólicas potencialmente serias como diabetes mellitus tipo 2 (DM2), esteatohepatitis e hipertrigliceridemia.Presentación del caso. Paciente femenina de 17 años con un diagnóstico tardío de LCG y con diabetes mellitus (erróneamente clasificada como tipo I), hipertrigliceridemia severa e infecciones a repetición. Luego de introducir metformina y un inhibidor del SGLT2 en el manejo de la paciente, se logró un adecuado control metabólico.Conclusión. Con frecuencia, el desconocimiento de algunas enfermedades huérfanas lleva a diagnósticos erróneos y, por tanto, a tratamientos inadecuados que en algunos casos pueden empeorar la condición clínica de los pacientes. Por lo anterior, en el caso de la LCG, es necesario que la comunidad médica tenga una mejor comprensión de sus aspectos diagnósticos y terapéuticos para brindar un diagnóstico y tratamiento oportunos.